Categories LATEST

Anti-climax: Tesla rival might bag Saudi investment

Apparently, it’s not just Tesla (TSLA) that Saudi Arabian sovereign wealth fund PIF is in talks with. Citing people familiar with the matter, Reuters reported that PIF is in talks with potential Tesla competitor Lucid Motors Inc for over $1 billion in funding. PIF is the same Saudi firm that Elon Musk hoped would help him in taking his company private.

Meanwhile, the sources stated that confirmation had not been made regarding the investment.

According to the term sheet, the first tranche of $500 million would initially be handed over to the Newark, California –based company and the rest would come up after the electric car maker meets some production deadlines. It may be noted that Lucid Motors has not started selling its vehicles though it has begun taking $2,500 as refundable deposits from interested parties.

Lucid Air (Image courtesy: Lucid Motors)

Related: Tesla board seeking No 2 exec

The company had released $100,000 luxury sedan prototype two years ago called Lucid Air, the production of which it expects to begin by the end of this year.

PIF, which has about $250 billion in assets, has made numerous investments in technology companies, including a $45 billion funding in a tech fund backed by SoftBank Group, according to Reuters.

Musk, who is facing the wrath of short-sellers and analysts for Tesla’s rampant cash burn, had stunned market pundits last week when he announced through a tweet his intention to take the company private. He later explained that he had held talks with PIF and was expecting the Saudi firm to provide the necessary funding.

However, with the latest development, the prospects of a massive investment in Tesla have just narrowed.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top